查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197520

医疗器械合同製造市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Medical Device Contract Manufacturing Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 106 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计在 2022 年至 2027 年的预测期内，医疗器械合同製造市场将以 10.5% 的复合年增长率增长。

儘管 COVID-19 大流行造成了中断，但医疗器械合同製造市场正在復苏，客户需求强劲。 这种强劲的增长也反映在外包供应商之间的併购活动中。 根据美国食品和药物管理局 (US-FDA) 2020 年更新，大流行还引发了对呼吸机、氧气浓缩器和 COVID-19 相关产品等医疗设备的前所未有的需求。 出于这个原因，通过合同製造公司开发医疗器械的外包活动变得更加活跃。 例如，2020 年 10 月，Relay Medical Co., Ltd. 和 Fio Co., Ltd. 与 FidNet Rapid Response Group 一起收购了总部位于美国的 Fionet 公司获得 FDA 批准的大流行应对设备，以提供交钥匙服务和全球覆盖。它将由 Keytronics 生产，Keytronics 是一家合同製造公司，用于 据报导，该公司最近正在製造与 COVID-19 相关的医疗设备。 此外，根据美国国立卫生研究院 (NIH) 2020 年 10 月的更新，该组织正在与生物医学高级研究与开发机构 (BARDA) 合作开发一种新的 COVID-19 测试技术，用于扩大和生产一系列测试。我们正在报告 3 轮合同签署。 因此，上述因素表明 COVID-19 大流行对市场增长产生了积极影响。

此外，医疗器械市场的增长和技术的进步是对市场增长做出重大贡献的因素。

医疗器械市场的增长是推动市场增长的关键因素。 例如，根据 2022 年世界卫生组织 (WHO) 更新，估计有 200 万种医疗器械被归入 7000 多个通用器械组。 同样在 2021 年 6 月，罗马尼亚 Rosti 赢得了新製造工厂的医疗设备合同。 这表明全球医疗器械市场正在扩大，对合同製造服务的需求不断增加。 此外，一些公司没有能力在内部製造医疗设备。 因此，医疗器械合同製造受到青睐，这反过来又推动了市场增长。

为了扩大医疗设备的使用，已经启动了多项举措。 例如，2021 年 10 月，印度政府宣布计划起草新药品、化妆品和医疗器械法案，以提高全球市场对医疗器械的接受度。 此外，据报导，2021 年 10 月，SpinaFX Medical Inc .与加拿大最大的医疗设备设计、开发和製造服务机构 StarFish Product Engineering Inc .签订了商业合同製造协议。

然而，医疗器械市场的整合成为阻碍医疗器械代工市场发展的主要因素。

医疗器械代工市场趋势

在医疗器械代工市场中，IVD器械板块有望占据最大市场份额

按设备划分，IVD 设备领域预计将占据很大份额。 这可能是由于新兴国家医院数量的增加、医疗基础设施的发展、全球体外诊断测试量的增加以及慢性病的高患病率等因素造成的。

体外诊断医疗设备是使用生物样本进行测试以了解人们健康状况的设备。 有各种各样的体外诊断医疗设备，从怀孕的自我诊断和糖尿病患者的血糖测试到临床实验室进行的高级诊断。 由于终端用户的高采用率，IVD 设备正在扩大其在医疗环境中的使用。 对医疗点 (POC) 设备和疾病监测、诊断和预防能力的需求正在推动这一领域的增长。 对个性化、先进和快速诊断设备的需求不断增长，将推动 IVD 设备的市场增长。

一些市场细分公司正在努力实施战略举措，以促进该细分市场的增长。 例如，2021 年 8 月，Tecan 收购了 Paramit，这是一家主要专注于医疗和生命科学设备的全球合同开发和製造公司。 收购 Paramit 有望进一步扩大帝肯在生命科学和体外诊断 (IVD) 解决方案领域的地位。

此外，2021 年 6 月，Somnix 和 Maxnerva Technology Services 就体外诊断 (IVD) 签订了合作合同开发和製造组织 (CDMO)。 此外，2021 年 11 月，BioFortuna 是一家体外诊断和即时检测设备的合同开发和製造公司，将搬迁到北威尔士迪赛德的一个新的最先进的工厂，将其生产规模扩大一倍容量。我被允许。

此外，随着世界范围内癌症疾病的增多，对体外诊断的需求越来越大，对体外诊断发展的製造服务需求也越来越大。

因此，由于上述因素，预计市场在预测期内将出现显着增长。

北美主导市场，预计在预测期内也会如此

在北美，美国占有很大的份额。 推动市场增长的主要因素是医疗保健支出的增加、慢性病的流行以及市场参与者的强大存在。

例如，根据美国疾病控制与预防中心 (CDC) 2022 年 2 月的更新，2020 年有 4.6% 的成年人被诊断出患有冠心病。 此外，根据美国国家癌症研究所 (NCI) 2020 年的统计数据，美国将有大约 1,806,590 例癌症病例，预计到 2030 年癌症倖存者将达到 220 万。 随着慢性病负担的增加，用于诊断和治疗的医疗器械的需求正在增加。 因此，对合同製造服务的需求预计会增加。

此外，市场进入者的多项举措也为市场的增长做出了贡献。 例如，2021 年 9 月，连接器和传感器领域的全球领导者 TE Con□□nectivity 将加入 Toolbox Medical Innovations（美国加利福尼亚州卡尔斯巴德），后者为 Point of Care IVD 产品提供开发、可用性测试、临床研究和製造服务。收购了 3 家专注于微流体试剂盒和吸塑试剂包开发、可用性测试、临床研究和製造的公司。

因此，由于上述市场发展，预计市场在预测期内将出现显着增长。

医疗器械代工市场竞争者分析

医疗器械合同製造市场竞争适中，由几家重要参与者组成。 就市场份额而言，一些主要参与者主导着市场。 此外，一些主要参与者正在积极收购其他公司以巩固其在全球市场的地位。 目前主导市场的公司包括 Biofortuna Limited、Jabil Inc.、Synecco、Gerresheimer AG 和 Invetech。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 不断发展的医疗器械市场
    • 技术进步
  • 市场製约因素
    • 医疗器械市场整合
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按设备
    • 体外诊断设备
      • 体外诊断医疗设备
      • 体外诊断医疗器械耗材
    • 诊断成像设备
    • 心脏病学相关产品
    • 药物输送设备
      • 注射器
      • 注射笔
      • 其他
    • 内窥镜设备
    • 眼科设备
    • 骨科设备
    • 牙科设备
    • 其他
  • 按服务
    • 设备开发和製造服务
      • 设备工程服务
      • 流程开发服务
      • 设备製造服务
    • 质量控制服务
      • 检验和测试服务
      • 包装验证服务
    • 组装服务
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Jabil Inc.
    • Synecco
    • Gerresheimer AG
    • Celestica Inc.
    • Nordson Corporation
    • Teleflex Incorporated
    • Integer Holdings Corporation
    • Nipro Corporation
    • SteriPack Group Ltd
    • TE Connectivity Ltd
    • Celestica International
    • Nortech Systems, Inc.
    • Invetech
    • Biofortuna Limited

第7章 市场机会与今后动向

简介目录
Product Code: 67523

The medical device contract manufacturing market is expected to register a CAGR of 10.5% over the forecast period, 2022-2027.

The contract manufacturing market for medical devices has rebounded with strong demand from customers despite the disruption caused by the COVID-19 pandemic. The strong uptick reflects this in outsourcing providers' merger and acquisition (M&A) activities. Also, as per a 2020 update by the United States Food and Drug Administration (US-FDA), the pandemic triggered an unprecedented demand for medical devices such as ventilators, oxygen concentrators, and COVID-19-related products. Thus, there has been an increase in outsourcing activities for developing medical devices through companies engaged in contract manufacturing. For instance, in October 2020, Relay Medical Corp. and Fio Corporation, together with Fidonet Rapid Response Group, reported that the United States-based would produce its Fionet pandemic response devices with an FDA-approved contract manufacturer, KeyTronic, which offers turnkey services and global reach. The company has reported making COVID-19-related medical devices recently. Also, per an October 2020 update by the National Institutes of Health (NIH), the organization is working in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), reporting the third round of contract awards for scale-up and manufacturing of new COVID-19 testing technologies. Thus, the factors above indicate that the COVID-19 pandemic has positively impacted the market's growth.

Furthermore, the significant factors contributing to the market's growth are the growing medical device market and technological advancements.

The growing medical device market is a significant factor driving the market's growth. For instance, as per the 2022 World Health Organization (WHO) update, there are an estimated 2 million different kinds of medical devices categorized into more than 7000 generic device groups. Also, in June 2021, Rosti Romania secured a new medical device contract for its new manufacturing facility. This indicates the growth in the medical devices market worldwide, which is increasing the demand for contract manufacturing services. Also, some companies do not have in-house capabilities for manufacturing medical devices. As a result, contract manufacturing of such devices is preferred, ultimately boosting the market's growth.

Several initiatives are being launched to expand the use of medical devices. For instance, in October 2021, the Indian government announced plans to draft a new drug, cosmetics, and medical device bill to increase the acceptability of medical devices in the global market. Additionally, in October 2021, SpinaFX Medical Inc. reported signing a commercialization contract manufacturing agreement with StarFish Product Engineering Inc., Canada's largest medical device design, development, and manufacturing services organization.

However, consolidation of the medical device market is a significant factor hindering the medical device contract manufacturing market.

Medical Device Contract Manufacturing Market Trends

IVD Device Segment is Expected to Hold the Largest Market Share in the Medical Device Contract Manufacturing Market

By devices, the IVD devices segment is anticipated to hold a significant share of the market. This can be attributed to factors such as growing numbers of hospitals in developing countries; development of healthcare infrastructure; rising IVD test volume worldwide, and the high prevalence of chronic diseases.

In vitro, diagnostic medical devices are tests used on biological samples to determine the status of a person's health. There is a broad range of in vitro diagnostics (IVDs), from self-tests for pregnancy and blood glucose tests for people with diabetes to sophisticated diagnoses performed in clinical laboratories. The use of IVD devices is increasing in medical facilities as the adoption rate for these devices is higher among end users. The demand for point-of-care devices and their ability to monitor, diagnose, and prevent diseases contribute to the segment's growth. The increased demand for personalized, advanced, and rapid diagnostic devices will boost market growth for IVD devices.

Several market players are engaged in implementing strategic initiatives, thereby contributing to the segment's growth. For instance, in August 2021, Tecan acquired Paramit, global contract development and manufacturing company mainly focused on medical devices and life sciences instruments. The acquisition of Paramit is believed to further expand Tecan's position in solutions for life sciences and in-vitro diagnostics (IVD).

Also, in June 2021, Somnics, Inc. and Maxnerva Technology Services signed a cooperation agreement regarding the contract development and manufacturing organization (CDMO) of in vitro diagnostic devices (IVD). Moreover, in November 2021, Biofortuna, a specialist contract development, and manufacturing partner to the IVD and point-of-care testing sectors, doubled its manufacturing capacity following its relocation to new state-of-the-art facilities in Deeside, North Wales.

Furthermore, with the increasing burden of cancer disorders worldwide, the demand for IVD devices is increasing, complementing the need for manufacturing services for developing in-vitro diagnostic devices.

Thus, the market is expected to witness significant growth over the forecast period due to the abovementioned factors.

North America Dominates the Market and Expected to do Same in the Forecast Period

Within North America, the United States has held a significant share of the market. The major factors fueling the market's growth are the growing expenditure on healthcare, the prevalence of chronic disorders, and the strong presence of market players.

For instance, as per a February 2022 update by the Centers for Disease Control and Prevention (CDC), in 2020, the percentage of adults who have ever been diagnosed with coronary heart disease was 4.6%. Additionally, as per the 2020 statistics by the National Cancer Institute (NCI), about 1,806,590 cases will be diagnosed in the United States in 2020, and the number of cancer survivors is projected to reach 2.2 million by 2030. Such an anticipated increase in the burden of chronic diseases is leading to high demand for medical devices used in diagnosing and treating such conditions. As a result, the need for contract manufacturing services is expected to rise.

Moreover, several initiatives undertaken by the market players contribute to the market's growth. For instance, in September 2021, TE Connectivity, a world leader in connectors and sensors, acquired three companies focused on microfluidic cartridge and blister reagent package development, usability testing, clinical research, and manufacturing, including Toolbox Medical Innovations (Carlsbad, California, USA), which provides development, usability testing, clinical research, and manufacturing services for Point of Care IVD products.

Thus, the market is expected to witness significant growth during the forecast period due to the above developments.

Medical Device Contract Manufacturing Market Competitor Analysis

The medical device contract manufacturing market is moderately competitive and consists of several significant players. In terms of market share, a few major players dominate the market. And some prominent players are vigorously making acquisitions of other companies to consolidate their global market positions. Some companies currently dominating the market are Biofortuna Limited, Jabil Inc., Synecco, Gerresheimer AG, and Invetech.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Medical Device Market
    • 4.2.2 Advancement in Technology
  • 4.3 Market Restraints
    • 4.3.1 Medical Device Market Consolidation
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Device
    • 5.1.1 IVD Devices
      • 5.1.1.1 IVD Equipments
      • 5.1.1.2 IVD Consumables
    • 5.1.2 Diagnostic Imaging Devices
    • 5.1.3 Cardiovascular Devices
    • 5.1.4 Drug Delivery Devices
      • 5.1.4.1 Syringes
      • 5.1.4.2 Pen Injectors
      • 5.1.4.3 Others
    • 5.1.5 Endoscopy Devices
    • 5.1.6 Ophthalmology Devices
    • 5.1.7 Orthopedic Devices
    • 5.1.8 Dental Devices
    • 5.1.9 Other Devices
  • 5.2 By Service
    • 5.2.1 Device Development and Manufacturing Service
      • 5.2.1.1 Device Engineering Service
      • 5.2.1.2 Process Development Service
      • 5.2.1.3 Device Manufacturing Service
    • 5.2.2 Quality Management Service
      • 5.2.2.1 Inspection & Testing Service
      • 5.2.2.2 Packaging Validation Service
    • 5.2.3 Assembly Service
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Jabil Inc.
    • 6.1.2 Synecco
    • 6.1.3 Gerresheimer AG
    • 6.1.4 Celestica Inc.
    • 6.1.5 Nordson Corporation
    • 6.1.6 Teleflex Incorporated
    • 6.1.7 Integer Holdings Corporation
    • 6.1.8 Nipro Corporation
    • 6.1.9 SteriPack Group Ltd
    • 6.1.10 TE Connectivity Ltd
    • 6.1.11 Celestica International
    • 6.1.12 Nortech Systems, Inc.
    • 6.1.13 Invetech
    • 6.1.14 Biofortuna Limited

7 MARKET OPPORTUNITIES AND FUTURE TRENDS